Coming to terms with tissue engineering and regenerative medicine in the lung

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Lung diseases such as emphysema, interstitial fibrosis, and pulmonary vascular diseases cause significant morbidity and mortality, but despite substantial mechanistic understanding, clinical management options for them are limited, with lung transplantation being implemented at end stages. However, limited donor lung availability, graft rejection, and long-term problems after transplantation are major hurdles to lung transplantation being a panacea. Bioengineering the lung is an exciting and emerging solution that has the ultimate aim of generating lung tissues and organs for transplantation. In this article we capture and review the current state of the art in lung bioengineering, from the multimodal approaches, to creating anatomically appropriate lung scaffolds that can be recellularized to eventually yield functioning, transplant-ready lungs. Strategies for decellularizing mammalian lungs to create scaffolds with native extracellular matrix components vs. de novo generation of scaffolds using biocompatible materials are discussed. Strengths vs. limitations of recellularization using different cell types of various pluripotency such as embryonic, mesenchymal, and induced pluripotent stem cells are highlighted. Current hurdles to guide future research toward achieving the clinical goal of transplantation of a bioengineered lung are discussed.

Original languageEnglish (US)
Pages (from-to)L625-L638
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume309
Issue number7
DOIs
StatePublished - Sep 1 2015

Keywords

  • Bioengineering
  • Decellularization
  • Pulmonary
  • Tissue engineering
  • Transplantation

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Fingerprint Dive into the research topics of 'Coming to terms with tissue engineering and regenerative medicine in the lung'. Together they form a unique fingerprint.

Cite this